TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.690
+0.190 (12.67%)
At close: Mar 9, 2026, 4:00 PM EDT
1.670
-0.020 (-1.18%)
After-hours: Mar 9, 2026, 7:58 PM EDT
TuHURA Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 6.96 | 4.31 | 4.14 | 2.01 |
| Research & Development | 18.45 | 13.34 | 9.4 | 7.93 |
| Operating Expenses | 25.42 | 17.65 | 13.55 | 9.93 |
| Operating Income | -25.42 | -17.65 | -13.55 | -9.93 |
| Interest Expense | -0.54 | -4.14 | -0.02 | - |
| Interest & Investment Income | 0.3 | 0.36 | 0.09 | 0.06 |
| Other Non Operating Income (Expenses) | 0.27 | -0.26 | 0.04 | 0.21 |
| EBT Excluding Unusual Items | -25.39 | -21.68 | -13.43 | -9.66 |
| Other Unusual Items | - | - | 0.33 | 0.29 |
| Pretax Income | -29.29 | -21.68 | -29.32 | -9.37 |
| Net Income | -29.29 | -21.68 | -29.32 | -9.37 |
| Preferred Dividends & Other Adjustments | 0.01 | 0.97 | - | - |
| Net Income to Common | -29.29 | -22.65 | -29.32 | -9.37 |
| Shares Outstanding (Basic) | 44 | 19 | 12 | - |
| Shares Outstanding (Diluted) | 44 | 19 | 12 | - |
| Shares Change (YoY) | -42.11% | 56.97% | - | - |
| EPS (Basic) | -0.66 | -1.21 | -2.47 | - |
| EPS (Diluted) | -0.66 | -1.21 | -2.47 | - |
| Free Cash Flow | -24.74 | -14.79 | -13.25 | -7.54 |
| Free Cash Flow Per Share | -0.56 | -0.79 | -1.11 | - |
| EBITDA | -25.35 | -17.53 | -13.37 | -9.56 |
| D&A For EBITDA | 0.07 | 0.12 | 0.18 | 0.37 |
| EBIT | -25.42 | -17.65 | -13.55 | -9.93 |
Source: S&P Capital IQ. Standard template.
Financial Sources.